Back to Search
JANICE HAINSWORTH, PHD.
PHD.
Psychologist
NPI: 1710038542Individual
Specialties, Licenses & Credentials
Professional Counselor
Counselor — Professional
Code: 101YP2500X
37PC00109200(NJ)
PsychologistPrimary
Psychologist
Code: 103T00000X
35SI00374100(NJ)
Research & Publications (20)
Treatment for patients with unknown primary cancer and favorable prognostic factors.
PMID 19179187·Semin Oncol·2009
6-review
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck.
PMID 19288572·Cancer·2009
3-trial
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.
PMID 19299236·Clin Breast Cancer·2009
3-trial
Follicular lymphoma in the United States: first report of the national LymphoCare study.
PMID 19204203·J Clin Oncol·2009
8-other
Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
PMID 19525191·Clin Lymphoma Myeloma·2009
3-trial
A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.
PMID 19433964·Am J Clin Oncol·2009
3-trial
Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer.
PMID 19661042·Clin Breast Cancer·2009
3-trial
A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib.
PMID 19272767·Eur J Cancer·2009
8-other
Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.
PMID 19255328·J Clin Oncol·2009
3-trial
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.
PMID 18650154·Clin Breast Cancer·2008
3-trial
High-dose etoposide: from phase I to a component of curative therapy.
PMID 18838698·J Clin Oncol·2008
8-other
Evaluation of dentists' perceived needs regarding treatment of the anxious patient.
PMID 18425075·Br Dent J·2008
8-other
A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.
PMID 18952556·Clin Breast Cancer·2008
3-trial
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
PMID 18640933·J Clin Oncol·2008
4-observational
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
PMID 18543319·Cancer·2008
3-trial
Psychosocial characteristics of adults who experience difficulties with retching.
PMID 18513848·J Dent·2008
8-other
Final survival and safety results from a multicenter, open-label, phase 3b trial of erlotinib in patients with advanced nonsmall cell lung cancer.
PMID 18438878·Cancer·2008
3-trial
Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
PMID 18802157·J Clin Oncol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 S CHURCH ST STE 11
MOUNT LAUREL, NJ 08054 - Phone
- (856) 366-7911
Quick Facts
- NPI
- 1710038542
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile